Cookie Consent by PrivacyPolicies.com

Publicaciones científicas

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)

28-nov-2016 | Revista: Clinical & Translational Oncology

de Las Peñas R (1), Blasco A (2), De Castro J (3), Escobar Y (4), García-Campelo R (5), Gúrpide A (6), Lopez-Lopez R (7), Majem M (8), Rodríguez CA (9), Virizuela JA (10).
(1) Servicio de Oncología Médica, Consorcio Hospital Provincial de Castellón, Avda. Dr. Clará, 19, 12002, Castellón de la Plana, Castellón, Spain.
(2) Servicio de Oncología Médica, Hospital General Universitario de Valencia, Valencia, Spain.
(3) Servicio de Oncología Médica, Hospital Universitario la Paz de Madrid, Madrid, Spain.
(4) Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón de Madrid, Madrid, Spain.
(5) Servicio de Oncología Médica, Complexo Hospitalario Universitario A Coruña (Hospital Juan Canalejo), A Coruña, Spain.
(6) Servicio de Oncología Médica, Clínica Universitaria de Navarra, Pamplona, Spain.
(7) Servicio de Oncología Médica, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
(8) Servicio de Oncología Médica, Hospital de la Santa Creu I Sant Pau de Barcelona, Barcelona, Spain.
(9) Servicio de Oncología Médica, Hospital Universitario de Salamanca, Salamanca, Spain.
(10) Servicio de Oncología Médica, Complejo Hospitalario Regional Virgen Macarena de Sevilla, Sevilla, Spain. 


RESUMEN

Chemotherapy-induced nausea and vomiting is one of the most worrisome adverse effects of chemotherapy for cancer patients.

It can cause severe discomfort and affect the quality of life. In recent years, the incorporation of new drugs has increased the efficacy of antiemetic treatments in the control of emesis associated with chemotherapy.

This guideline, in which we give some treatment recommendations with level of evidence and grade of recommendation, provides an update of the previously published guideline of the Spanish Society of Medical Oncology and represents our continued commitment to improving supportive care in cancer patients.

CITA DEL ARTÍCULO  Clin Transl Oncol. 2016 Nov 28

Nuestros autores